| Laporsha Miller, LPN | |
|
515 Clanton Rd, Charlotte, NC 28217-1309 | |
| (704) 332-9001 | |
| Not Available |
| Full Name | Laporsha Miller |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 515 Clanton Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194131540 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 79948 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laporsha Miller, LPN 515 Clanton Rd, Charlotte, NC 28217-1309 Ph: (704) 332-9001 | Laporsha Miller, LPN 515 Clanton Rd, Charlotte, NC 28217-1309 Ph: (704) 332-9001 |
News Archive
Researchers in China have demonstrated interferon-alpha (IFN-α) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-α priming was shown to promote lipid uptake and foam cell formation—a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).
'Goldilocks' gene could determine best treatment for TB patients Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene, says an international research team from Oxford University, King's College London, Vietnam and the USA.
Myeloma UK is launching a new research program to continue support for patient-centric myeloma clinical trials in the UK, the UK Myeloma Research Alliance-Myeloma UK-Concept and Access Research Programme.
Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role played by the biomarker microRNA (miR)-506 in gastric cancer.
› Verified 8 days ago
Mrs. Keely Pritchard, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 515 Clanton Rd, Charlotte, NC 28217 Phone: 704-332-9001 | |
Avita Wade, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5110 Misty Oaks Dr Apt 1813, Charlotte, NC 28269 Phone: 843-641-8326 | |
Ms. Tiwana Stampley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5103 Milhaven Ln, Charlotte, NC 28269 Phone: 980-365-1300 | |
Ms. Rosa Anna Dileo, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7906 Lawyers Rd, Charlotte, NC 28227 Phone: 704-532-4348 | |
Ms. Renee Davis, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7825 Angele Ln Apt 1427, Charlotte, NC 28262 Phone: 631-772-6762 | |
Fatima Wilds, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8643 Bodkin Ct, Charlotte, NC 28215 Phone: 336-225-6912 | |
Paul Steven Gust, CRNA Licensed Practical Nurse Medicare: Accepting Medicare Assignments Practice Location: 1000 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-2000 |